Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)

0
442

Funding Opportunity ID: 309783
Opportunity Number: RFA-FD-20-001
Opportunity Title: Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.103
Eligible Applicants: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Additional Information on Eligibility:
Agency Code: HHS-FDA
Agency Name: Department of Health and Human Services
Food and Drug Administration
Posted Date: Oct 23, 2018
Close Date: Jun 25, 2019
Last Updated Date: Oct 23, 2018
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding:
Expected Number of Awards: 15
Description: The purpose of this funding opportunity announcement (FOA) is to support clinical studies of products that address unmet needs in rare diseases or conditions or provide highly significant improvements in treatment or diagnosis. Through the support of efficient and innovative clinical studies evaluating safety and/or effectiveness, FDA expects to increase the number of treatments for rare diseases with an unmet medical need and support studies that will either result in market approval of these products or substantially contribute to the essential data needed for medical product development that will ultimately meet the needs of rare disease patients.
Version: 1





Visit the Official Webpage For More Details on Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)